Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given New $8.00 Price Target at Stifel Nicolaus

Posted by Francis Steltz on May 11th, 2026

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) had its target price cut by research analysts at Stifel Nicolaus from $9.00 to $8.00 in a report issued on Monday,Benzinga reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ price objective points to a potential upside of 50.43% from the stock’s previous close.

Separately, Weiss Ratings began coverage on shares of Senseonics Holdings, Inc. Common Stock in a research note on Tuesday, February 17th. They issued a “sell (d-)” rating on the stock. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $18.13.

Check Out Our Latest Stock Report on Senseonics Holdings, Inc. Common Stock

Senseonics Holdings, Inc. Common Stock Trading Up 5.7%

SENS stock opened at $5.32 on Monday. The stock has a market cap of $222.29 million, a PE ratio of -2.63 and a beta of 1.05. Senseonics Holdings, Inc. Common Stock has a 12 month low of $4.79 and a 12 month high of $13.40. The business’s 50-day moving average price is $6.64. The company has a debt-to-equity ratio of 0.58, a quick ratio of 4.55 and a current ratio of 4.83.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported ($0.71) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.65) by ($0.06). The business had revenue of $11.71 million during the quarter. Senseonics Holdings, Inc. Common Stock had a negative return on equity of 111.78% and a negative net margin of 213.87%. Sell-side analysts forecast that Senseonics Holdings, Inc. Common Stock will post -2.83 EPS for the current year.

Insider Buying and Selling at Senseonics Holdings, Inc. Common Stock

In other news, CEO Timothy T. Goodnow bought 17,225 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction that occurred on Friday, March 13th. The shares were purchased at an average price of $5.79 per share, with a total value of $99,732.75. Following the completion of the acquisition, the chief executive officer directly owned 651,243 shares in the company, valued at $3,770,696.97. The trade was a 2.72% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Douglas A. Roeder purchased 17,500 shares of the business’s stock in a transaction on Friday, March 13th. The stock was acquired at an average price of $5.73 per share, for a total transaction of $100,275.00. Following the completion of the purchase, the director owned 119,731 shares of the company’s stock, valued at $686,058.63. This represents a 17.12% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 4.70% of the stock is owned by insiders.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Kestra Advisory Services LLC purchased a new position in shares of Senseonics Holdings, Inc. Common Stock during the first quarter worth about $68,000. GSK plc acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock during the fourth quarter worth $60,000. Townsend Asset Management Corp NC ADV purchased a new position in Senseonics Holdings, Inc. Common Stock in the 4th quarter valued at $60,000. Sanctuary Advisors LLC acquired a new position in Senseonics Holdings, Inc. Common Stock in the 4th quarter valued at $71,000. Finally, Captrust Financial Advisors acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 4th quarter worth $77,000. 12.36% of the stock is owned by institutional investors and hedge funds.

About Senseonics Holdings, Inc. Common Stock

(Get Free Report)

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.